neostigmine has been researched along with Metabolism, Inborn Errors in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Metabolism, Inborn Errors: Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cassel, J | 1 |
Staehr-Rye, AK | 1 |
Nielsen, CV | 1 |
Gätke, MR | 1 |
MCDONALD, I | 1 |
2 other studies available for neostigmine and Metabolism, Inborn Errors
Article | Year |
---|---|
Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
Topics: Accelerometry; Aged; Antidotes; Apnea; Appendicitis; Butyrylcholinesterase; Cholecystectomy, Laparos | 2014 |
A CASE OF SUXAMETHONIUM SENSITIVITY.
Topics: Anesthesia; Anesthesiology; Apnea; Atropine; Bis-Trimethylammonium Compounds; Butyrylcholinesterase; | 1963 |